-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$34.00281.17% Upside
REGENXBIO Inc. Frequently Asked Questions
-
What analysts cover REGENXBIO Inc.?
REGENXBIO Inc. has been rated by research analysts at Raymond James, H.C. Wainwright, Stifel Nicolaus, Goldman Sachs, RBC Capital in the past 90 days.